David Newman-Toker

Dr. David E. Newman-Toker, MD PhD, is an internationally-recognized leader in neuro-otology, acute stroke diagnosis, and the study of diagnostic errors.

With a diverse educational background including PhD in Clinical Investigation from Johns Hopkins Bloomberg School of Public Health, MD in Medicine from the University of Pennsylvania, and BS in Molecular Biophysics & Biochemistry from Yale University, Dr. Newman-Toker has gained extensive knowledge in his field.

As a full-time faculty member at Johns Hopkins University School of Medicine since 2002, Dr. Newman-Toker holds the title of Professor in various departments including Neurology, Otolaryngology, and Ophthalmology with joint appointments in several other disciplines.

His clinical and research focus lies in diagnosing acute disorders affecting the brainstem and cranial nerves, particularly stroke, making him the Director of the Division of Neuro-Visual & Vestibular Disorders in the Department of Neurology at Johns Hopkins.

Dr. Newman-Toker's contributions extend beyond his clinical work as he also directs the Armstrong Institute Center for Diagnostic Excellence, aiming to improve diagnostic performance, safety, and research.

With numerous publications and invited lectures on dizziness and diagnostic errors, he is a prominent figure in the national and international movements to enhance patient safety by minimizing diagnostic errors.

Furthermore, his role as President-Elect of the Society to Improve Diagnosis in Medicine and Chair of SIDM's Policy Committee showcases his dedication to advancing diagnostic practices and quality in healthcare.

His expertise has been acknowledged through his consultation services to organizations like AHRQ, the National Academy of Medicine, and the National Quality Forum.

Dr. David Newman-Toker's professional journey encompasses a remarkable blend of academics, clinical practice, research, and leadership in shaping the future of accurate diagnosis in medical care.